Advertisement
Screener

STRYKER CORP (SYK) Cash and Cash Equivalents, Period Increase (Decrease)

2.8 / 5 stars · 66/120 Roast Me

STRYKER CORP Cash and Cash Equivalents, Period Increase (Decrease)

STRYKER CORP (SYK) reported Cash and Cash Equivalents, Period Increase (Decrease) of $721.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-06.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-02-06

  • STRYKER CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was $2.39B, a 40.69% increase year-over-year.
  • STRYKER CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $194.00M, a 29.96% decline year-over-year.
  • STRYKER CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $80.00M.
  • STRYKER CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$1.94B.
  • STRYKER CORP cash and cash equivalents, period increase (decrease) for fiscal 2019 was $721.00M, a 32.87% decline from fiscal 2018.
  • STRYKER CORP cash and cash equivalents, period increase (decrease) for fiscal 2018 was $1.07B.
  • STRYKER CORP cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$774.00M.
  • STRYKER CORP cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$63.00M, a 103.98% decline from fiscal 2015.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 3 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 6 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 9 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 12 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed
2019-12-31$2.39B
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06
$2.58B
derived: sum of 2 quarters · filed 2020-02-06
$2.66B
derived: sum of 3 quarters · filed 2020-02-06
$721.00M
10-K · filed 2020-02-06
2019-09-30$194.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
$274.00M
derived: sum of 2 quarters · filed 2019-10-30
-$1.67B
10-Q · filed 2019-10-30
$30.00M
derived: sum of 4 quarters · filed 2020-02-06
2019-06-30$80.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26
-$1.86B
10-Q · filed 2019-07-26
-$164.00M
derived: sum of 3 quarters · filed 2020-02-06
$113.00M
derived: sum of 4 quarters · filed 2020-02-06
2019-03-31-$1.94B
10-Q · filed 2019-04-24
-$244.00M
derived: sum of 2 quarters · filed 2020-02-06
$33.00M
derived: sum of 3 quarters · filed 2020-02-06
-$505.00M
derived: sum of 4 quarters · filed 2020-02-06
2018-12-31$1.70B
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06
$1.98B
derived: sum of 2 quarters · filed 2020-02-06
$1.44B
derived: sum of 3 quarters · filed 2020-02-06
$1.07B
10-K · filed 2020-02-06
2018-09-30$277.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
-$261.00M
derived: sum of 2 quarters · filed 2019-10-30
-$624.00M
10-Q · filed 2019-10-30
-$674.00M
derived: sum of 4 quarters · filed 2020-02-06
2018-06-30-$538.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26
-$901.00M
10-Q · filed 2019-07-26
-$951.00M
derived: sum of 3 quarters · filed 2020-02-06
-$2.01B
derived: sum of 4 quarters · filed 2020-02-06
2018-03-31-$363.00M
10-Q · filed 2019-04-24
-$413.00M
derived: sum of 2 quarters · filed 2020-02-06
-$1.47B
derived: sum of 3 quarters · filed 2020-02-06
-$1.03B
derived: sum of 4 quarters · filed 2020-02-06
2017-12-31-$50.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06
-$1.11B
derived: sum of 2 quarters · filed 2020-02-06
-$671.00M
derived: sum of 3 quarters · filed 2020-02-06
-$774.00M
10-K · filed 2020-02-06
2017-09-30-$1.06B
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26
-$621.00M
derived: sum of 2 quarters · filed 2018-10-26
-$724.00M
10-Q · filed 2018-10-26
-$361.00M
derived: sum of 4 quarters · filed 2019-02-07
2017-06-30$436.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25
$333.00M
10-Q · filed 2018-07-25
$696.00M
derived: sum of 3 quarters · filed 2019-02-07
$159.00M
derived: sum of 4 quarters · filed 2019-02-07
2017-03-31-$103.00M
10-Q · filed 2018-04-27
$260.00M
derived: sum of 2 quarters · filed 2019-02-07
-$277.00M
derived: sum of 3 quarters · filed 2019-02-07
-$3.76B
derived: sum of 4 quarters · filed 2019-02-07
2016-12-31$363.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07
-$174.00M
derived: sum of 2 quarters · filed 2019-02-07
-$3.66B
derived: sum of 3 quarters · filed 2019-02-07
-$63.00M
10-K · filed 2019-02-07
2016-09-30-$537.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27
-$4.02B
derived: sum of 2 quarters · filed 2017-10-27
-$426.00M
10-Q · filed 2017-10-27
-$210.00M
derived: sum of 4 quarters · filed 2018-02-08
2016-06-30-$3.49B
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28
$111.00M
10-Q · filed 2017-07-28
$327.00M
derived: sum of 3 quarters · filed 2018-02-08
-$136.00M
derived: sum of 4 quarters · filed 2018-02-08
2016-03-31$3.60B
10-Q · filed 2017-04-27
$3.81B
derived: sum of 2 quarters · filed 2018-02-08
$3.35B
derived: sum of 3 quarters · filed 2018-02-08
$5.30B
derived: sum of 4 quarters · filed 2018-02-08
2015-12-31$216.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08
-$247.00M
derived: sum of 2 quarters · filed 2018-02-08
$1.71B
derived: sum of 3 quarters · filed 2018-02-08
$1.58B
10-K · filed 2018-02-08
2015-09-30-$463.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28
$1.49B
derived: sum of 2 quarters · filed 2016-10-28
$1.37B
10-Q · filed 2016-10-28
$1.81B
derived: sum of 4 quarters · filed 2017-02-09
2015-06-30$1.95B
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-22
$1.83B
10-Q · filed 2016-07-22
$2.27B
derived: sum of 3 quarters · filed 2017-02-09
$2.31B
derived: sum of 4 quarters · filed 2017-02-09
2015-03-31-$121.00M
10-Q · filed 2016-04-22
$318.00M
derived: sum of 2 quarters · filed 2017-02-09
$355.00M
derived: sum of 3 quarters · filed 2017-02-09
$293.00M
derived: sum of 4 quarters · filed 2017-02-09
2014-12-31$439.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09
$476.00M
derived: sum of 2 quarters · filed 2017-02-09
$414.00M
derived: sum of 3 quarters · filed 2017-02-09
$456.00M
10-K · filed 2017-02-09
2014-09-30$37.00M
10-Q · filed 2014-10-23
-$25.00M
derived: sum of 2 quarters · filed 2014-10-23
$17.00M
10-Q · filed 2015-10-23
$246.00M
derived: sum of 4 quarters · filed 2016-02-11
2014-06-30-$62.00M
10-Q · filed 2014-07-24
-$20.00M
10-Q · filed 2015-07-29
$209.00M
derived: sum of 3 quarters · filed 2016-02-11
$348.00M
derived: sum of 4 quarters · filed 2016-02-11
2014-03-31$42.00M
10-Q · filed 2015-04-30
$271.00M
derived: sum of 2 quarters · filed 2016-02-11
$410.00M
derived: sum of 3 quarters · filed 2016-02-11
-$532.00M
derived: sum of 4 quarters · filed 2016-02-11
2013-12-31$229.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11
$368.00M
derived: sum of 2 quarters · filed 2016-02-11
-$574.00M
derived: sum of 3 quarters · filed 2016-02-11
-$56.00M
10-K · filed 2016-02-11
2013-09-30$139.00M
10-Q · filed 2014-10-23
-$803.00M
derived: sum of 2 quarters · filed 2014-10-23
-$285.00M
10-Q · filed 2014-10-23
-$313.00M
derived: sum of 4 quarters · filed 2015-02-12
2013-06-30-$942.00M
10-Q · filed 2014-07-24
-$424.00M
10-Q · filed 2014-07-24
-$452.00M
derived: sum of 3 quarters · filed 2015-02-12
-$422.00M
derived: sum of 4 quarters · filed 2015-02-12
2013-03-31$518.00M
10-Q · filed 2014-04-24
$490.00M
derived: sum of 2 quarters · filed 2015-02-12
$520.00M
derived: sum of 3 quarters · filed 2015-02-12
$1.22B
derived: sum of 4 quarters · filed 2015-02-12
2012-12-31-$28.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12
$2.00M
derived: sum of 2 quarters · filed 2015-02-12
$705.00M
derived: sum of 3 quarters · filed 2015-02-12
$490.00M
10-K · filed 2015-02-12
2012-09-30$30.00M
10-Q · filed 2013-10-23
$733.00M
derived: sum of 2 quarters · filed 2013-10-23
$518.00M
10-Q · filed 2013-10-23
$613.00M
derived: sum of 4 quarters · filed 2014-02-13
2012-06-30$703.00M
10-Q · filed 2013-07-23
$488.00M
10-Q · filed 2013-07-23
$583.00M
derived: sum of 3 quarters · filed 2014-02-13
$896.00M
derived: sum of 4 quarters · filed 2014-02-13
2012-03-31-$215.00M
10-Q · filed 2013-04-30
-$120.00M
derived: sum of 2 quarters · filed 2014-02-13
$193.00M
derived: sum of 3 quarters · filed 2014-02-13
-$45.00M
derived: sum of 4 quarters · filed 2014-02-13
2011-12-31$95.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13
$408.00M
derived: sum of 2 quarters · filed 2014-02-13
$170.00M
derived: sum of 3 quarters · filed 2014-02-13
-$853.00M
10-K · filed 2014-02-13
2011-09-30$313.00M
10-Q · filed 2012-10-22
$75.00M
derived: sum of 2 quarters · filed 2012-10-22
-$948.00M
10-Q · filed 2012-10-22
-$116.00M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-30-$238.00M
10-Q · filed 2012-07-24
-$1.26B
10-Q · filed 2012-07-24
-$1.26B
10-Q · filed 2011-07-28
-$429.00M
derived: sum of 3 quarters · filed 2013-02-27
-$289.00M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-31-$1.02B
10-Q · filed 2012-04-24
-$1.02B
10-Q · filed 2011-05-04
-$191.00M
derived: sum of 2 quarters · filed 2013-02-27
-$51.00M
derived: sum of 3 quarters · filed 2013-02-27
-$468.30M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-31$832.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$972.00M
derived: sum of 2 quarters · filed 2013-02-27
$554.70M
derived: sum of 3 quarters · filed 2013-02-27
$1.10B
10-K · filed 2013-02-27
$1.10B
10-K · filed 2011-02-18
2010-09-30$140.00M
10-Q · filed 2011-10-28
$140.40M
10-Q · filed 2010-11-04
-$277.30M
derived: sum of 2 quarters · filed 2011-10-28
$267.00M
10-Q · filed 2011-10-28
$266.90M
10-Q · filed 2010-11-04
-$34.70M
derived: sum of 4 quarters · filed 2012-02-13
2010-06-30-$417.30M
10-Q · filed 2011-07-28
$126.50M
10-Q · filed 2011-07-28
-$174.70M
derived: sum of 3 quarters · filed 2012-02-13
$119.30M
derived: sum of 4 quarters · filed 2012-02-13
2010-03-31$543.80M
10-Q · filed 2011-05-04
$242.60M
derived: sum of 2 quarters · filed 2012-02-13
$536.60M
derived: sum of 3 quarters · filed 2012-02-13
$517.10M
derived: sum of 4 quarters · filed 2012-02-13
2009-12-31-$301.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13
-$7.20M
derived: sum of 2 quarters · filed 2012-02-13
-$26.70M
derived: sum of 3 quarters · filed 2012-02-13
-$42.00M
10-K · filed 2012-02-13
-$42.40M
10-K · filed 2010-02-26
2009-09-30$294.00M
10-Q · filed 2010-11-04
$274.50M
derived: sum of 2 quarters · filed 2010-11-04
$259.20M
10-Q · filed 2010-11-04
$292.30M
derived: sum of 4 quarters · filed 2011-02-18
2009-06-30-$19.50M
10-Q · filed 2010-08-09
-$34.80M
10-Q · filed 2010-08-09
-$1.70M
derived: sum of 3 quarters · filed 2011-02-18
$244.70M
derived: sum of 4 quarters · filed 2011-02-18
2009-03-31-$15.30M
10-Q · filed 2010-04-29
$17.80M
derived: sum of 2 quarters · filed 2011-02-18
$264.20M
derived: sum of 3 quarters · filed 2011-02-18
$262.30M
derived: sum of 4 quarters · filed 2011-02-18
2008-12-31$33.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18
$279.50M
derived: sum of 2 quarters · filed 2011-02-18
$277.60M
derived: sum of 3 quarters · filed 2011-02-18
$410.60M
10-K · filed 2011-02-18
2008-09-30$246.40M
10-Q · filed 2009-11-09
$244.50M
derived: sum of 2 quarters · filed 2009-11-09
$377.50M
10-Q · filed 2009-11-09
2008-06-30-$1.90M
10-Q/A · filed 2009-09-03
$131.10M
10-Q/A · filed 2009-09-03
2007-12-31-$126.10M
10-K · filed 2010-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
3M CO (MMM)United States$86.404B27.87
BOSTON SCIENTIFIC CORP (BSX)United States$64.781B17.29
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
DEXCOM INC (DXCM)United States$33.004B25.42
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12